Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate

Chronic inflammation is a risk factor for the onset of cancer and the regular use of aspirin reduces the risk of cancer development. Here we showed that therapeutic dosages of aspirin counteract the pro-tumorigenic effects of the inflammatory cytokine interleukin(IL)-6 in cancer and non-cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Brighenti, Elisa, Giannone, Ferdinando Antonino, Fornari, Francesca, Onofrillo, Carmine, Govoni, Marzia, Montanaro, Lorenzo, Treré, Davide, Derenzini, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325359/
https://www.ncbi.nlm.nih.gov/pubmed/27557515
http://dx.doi.org/10.18632/oncotarget.11441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325359/
https://www.ncbi.nlm.nih.gov/pubmed/27557515
http://dx.doi.org/10.18632/oncotarget.11441

Ejemplares similares